{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigz4usbpf6jomy6jfmqkfpf5kmief3gkhz5kyftfxhtreltxuxhwi",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mg3sfjaptwd2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieylr3bxxjxp7etw72mk5amt63siinkk3q5xvkwq5xeayz2vxyhai"
    },
    "mimeType": "image/jpeg",
    "size": 45719
  },
  "path": "/2026/03/02/uniqure-huntingtons-disease-fda-blocked/?utm_campaign=rss",
  "publishedAt": "2026-03-02T12:36:57.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "drug development",
    "FDA",
    "Pharmaceuticals",
    "rare diseases",
    "STAT+"
  ],
  "textContent": "UniQure said plans to seek approval for its Huntington’s disease treatment with the FDA remain blocked.",
  "title": "STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA",
  "updatedAt": "2026-03-02T12:40:45.000Z"
}